I'm LongbridgeAI, I can summarize articles.Wall Street analysts revised price targets for several tech and biotech stocks. Baird raised CrowdStrike's target to $235, while Rothschild & Co upgraded Moderna's target to $81 but downgraded its rating to Sell. Other changes include increases for UiPath, Netskope, Snowflake, Magnite, Broadcom, and DraftKings, alongside cuts for Ultragenyx and Sonoco. Most analyst ratings were maintained.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- HC Wainwright & Co. cut the price target for Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) from $50 to $25. HC Wainwright & Co. analyst Raghuram Selvaraju maintained a Buy rating. Ultragenyx Pharmaceutical shares closed at $26.53 on Wednesday. See how other analysts view this stock.
- Needham increased UiPath Inc (NASDAQ:PATH) price target from $15 to $22. Needham analyst Scott Berg maintained a Buy rating. UiPath shares closed at $17.99 on Wednesday. See how other analysts view this stock.
- BTIG boosted price target for Netskope Inc (NASDAQ:NTSK) from $17 to $18. BTIG analyst Gray Powell maintained a Buy rating. Netskope shares closed at $13.75 on Wednesday. See how other analysts view this stock.
- BTIG raised the price target for Snowflake Inc (NYSE:SNOW) from $340 to $424. BTIG analyst Gray Powell maintained a Buy rating. Snowflake shares closed at $305.84 on Wednesday. See how other analysts view this stock.
- Needham increased Magnite Inc (NASDAQ:MGNI) price target from $25 to $30. Needham analyst Laura Martin maintained a Buy rating. Magnite shares closed at $24.88 on Wednesday. See how other analysts view this stock.
- Cantor Fitzgerald boosted Broadcom Inc (NASDAQ:AVGO) price target from $525 to $600. Cantor Fitzgerald analyst C.J. Muse maintained an Overweight rating. Broadcom shares closed at $367.24 on Wednesday. See how other analysts view this stock.
- Baird raised Crowdstrike Holdings Inc (NASDAQ:CRWD) price target from $230 to $235. Baird analyst Shrenik Kothari maintained a Neutral rating. Crowdstrike shares closed at $203.42 on Wednesday. See how other analysts view this stock.
- Rothschild & Co raised the price target for Moderna Inc (NASDAQ:MRNA) from $40 to $81. Rothschild & Co analyst Simon Baker downgraded the stock from Neutral to Sell. Moderna shares closed at $150.81 on Wednesday. See how other analysts view this stock.
- B of A Securities cut Sonoco Products Co (NYSE:SON) price target from $69 to $60. B of A Securities analyst George Staphos downgraded the stock from Buy to Neutral. Sonoco shares closed at $54.74 on Wednesday. See how other analysts view this stock.
- Bernstein raised DraftKings Inc (NASDAQ:DKNG) price target from $27 to $29. Bernstein analyst Ian Moore maintained an Outperform rating. DraftKings shares closed at $24.21 on Wednesday. See how other analysts view this stock.
Considering buying CRWD stock? Here’s what analysts think: